‘All hands on deck’: How Duke University and AI for Health raced to create a COVID-19 solution for patients
The 7-month-old was crying. Amanda Randles picked her up, held her and continued talking on the video meeting call from home. Nearby, her other 7-month-old baby started to wail. Randles put one baby down, picked…
Phitonex Runs First 45 Color Flow Cytometry Analysis from a Single Sample
NEWS PROVIDED BY Phitonex, Inc. Nov 12, 2020, 09:00 ET DURHAM, N.C., Nov. 12, 2020 /PRNewswire/ — Phitonex, Inc., developers of next generation fluorescent labels for biomarker detection, has pushed the boundaries of cell biology today in…
Istari Oncology Presents Positive Data from Phase 1 Study
Istari Oncology Presents Positive Data from Phase 1 Study of PVSRIPO in Patients with Unresectable Treatment Refractory Melanoma at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting Data suggest that PVSRIPO, either…
Cohere-Med Spins Out Suite of AI-based Predictive Analytics
Cohere-Med Inc., a San Francisco based health data science startup, has spun out a suite of artificial intelligence-based predictive analytics and algorithms from Duke University. Following last year’s announcement of licensing the Sepsis Watch algorithm…
Releviate Therapeutics Inks Exclusive License for Human Monoclonal Antibodies for Chronic Pain Indications
Therapies Based on Extensive Neuropathic Pain Research Conducted at UC Riverside and Duke University Target Chronic Pain at Its Source: Matrix Metalloproteinases October 28, 2020 09:10 AM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Releviate™ Therapeutics, a…
KēlaHealth Raises $12.9M in Combined Seed and Series A Financing Round
KēlaHealth’s risk prediction and intervention platform shows quality improvements in surgery and reduced costs for hospitals SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ — KēlaHealth, Inc., a surgical intelligence platform that applies a dynamic cycle of patient-specific predictions,…
Tellus Receives Orphan Drug/Rare Pediatric Disease Designations
With No Approved Treatments for Diffuse White Matter Injury in Preterm Infants, FDA Decision Highlights Significant Unmet Need DURHAM, NORTH CAROLINA, UNITED STATES, October 21, 2020 /EINPresswire.com/ — Tellus Therapeutics, a neonatal care company developing…
Polarean Files NDA for Lung Diagnostic, Possible COVID-19 Aid
Polarean, a Duke University spinout, is another step closer to commercializing its proprietary technology for lung imaging. This month, the Durham-based medical imaging company submitted a New Drug Application to the U.S. Food and Drug…
Precision and SpringWorks Announce Clinical Collaboration
Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma Increasing BCMA Surface Expression and Reduced Soluble BCMA Levels with Gamma Secretase…